Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987

Size: px
Start display at page:

Download "Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987"

Transcription

1 Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of Genomics : 1987 Editorial A New Discipline, A New Name, A New Journal Genomics (1987) For the newly developing discipline of [genome] mapping/sequencing (including the analysis of the information), we have adopted the term GENOMICS. The new discipline is born from a marriage of molecular and cell biology with classical genetics and is fostered by computational science. Eric D. Green, MD, PhD 1

2 Human Genome Project: Myriad Applications of Genomics Health, Disease, & Medicine Genomic Medicine An emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., diagnostic or therapeutic decision making) and the other implications of that clinical use. Eric D. Green, MD, PhD 2

3 The Path to Genomic Medicine Human Genome Project Realization of Genomic Medicine Nature International weekly journal of science (2003) A vision for the future of genomics research (2011) Charting a course for genomic medicine from base pairs to bedside Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Eric D. Green, MD, PhD 3

4 ~3,000 bp (0.0001%) of Human Genome Sequence ENCODE: Giving GPS Views of Genomes Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Eric D. Green, MD, PhD 4

5 A vision for the future of genomics research: A blueprint for the genomic era (2003) Nature technological leaps that seem so far off as to be almost fictional but which, if they could be achieved, would revolutionize biomedical research and clinical practice. [For example,] the ability to sequence DNA at costs that are lower by four to five orders of magnitude than the current cost, allowing a human genome to be sequenced for $1000 or less. The $1,000 genome (2014) Nature With a unique programme, the US government has managed to drive the cost of genome sequencing down towards a much anticipated target. Erika Check Hayden (2014) Nature Sequencing a Human Genome Human Genome Project (1 st Sequence) ~1B ~6 8 years Today ~$2 4K ~1 3 days Eric D. Green, MD, PhD 5

6 Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Cataloging Human Genomic Variation Human Genetic Variation Your Genome: By the Numbers ~6B nucleotides ~3 5M single nucleotide variants ~150K not in databases ~60 not in either parent ~ disruptive variants in genes ~20 completely inactivated genes (both copies) Eric D. Green, MD, PhD 6

7 Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Cataloging Human Genomic Variation Elucidating the Genomic Bases of Disease Genomic Architecture of Genetic Diseases Manolio et al., J Clin Invest (2008) Rare, Simple, Monogenic, Mendelian Common, Complex, Multigenic, Non Mendelian Bringing Genomic Medicine into Focus Interpreting the Human Genome Sequence Developing New Genome Sequencing Methods Cataloging Human Genomic Variation Elucidating the Genomic Bases of Disease Implementing Genomic Medicine Eric D. Green, MD, PhD 7

8 Hot Areas in Genomic Medicine Cancer Genomics Cancer is a Disease of the Genome It takes several mutations to make a cell malignant Routine Clinical Diagnostic Tools Radiographic Imaging Cancer Genome Sequencing Eric D. Green, MD, PhD 8

9 Genomics and Cancer: Here and Now Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Pharmacogenomics Drug toxic but beneficial Drug toxic but NOT beneficial Drug NOT toxic and NOT beneficial Drug Not toxic and beneficial Eric D. Green, MD, PhD 9

10 Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics When Disease Strikes from Nowhere (2014) Nature Children born with disorders not readily explained by standard tests can sometimes be diagnosed through genome sequencing and analysis. NIH Undiagnosed Diseases Network: Seven clinical sites and a coordinating center Stanford Medicine UCLA Baylor College of Medicine National Institutes of Health Vanderbilt University Medical Center Harvard Teaching Hospitals Harvard Medical School Duke University Eric D. Green, MD, PhD 10

11 Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics Genomic Medicine Test Drive Programs Clinical Sequencing Exploratory Research (CSER) Implementing Genomics into Clinical Practice Network (IGNITE) Eric D. Green, MD, PhD 11

12 Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics Genomic Medicine Test Drive Programs Prenatal & Newborn Genomic Analysis Noninvasive Prenatal Genome Sequencing Newborn Sequencing in Genomic medicine and public Health (INSIGHT) Eric D. Green, MD, PhD 12

13 Hot Areas in Genomic Medicine Cancer Genomics Pharmacogenomics Ultra Rare Genetic Disease Diagnostics Genomic Medicine Test Drive Programs Prenatal & Newborn Genomic Analysis Clinical Genomics Information Systems Generating a Human Genome Sequence is (Almost) Trivial Clinical Genomics Information Systems Clinical Genome Resource (ClinGen) ClinGen: Sharing Data. Bluilding Knowledge. Improving Care. Eric D. Green, MD, PhD 13

14 The Relevance of Genomics Biomedical Researchers Healthcare Professionals Patients (and Friends & Relatives of Patients) Pervasive DNA & Genomic Imagery Genomics and Society Eric D. Green, MD, PhD 14

15 Genetic Genomic Competency Center (G2C2) Access resources to learn more about use of genomic information in your practice Education repository of resources for diverse healthcare professionals Global Genetics & Genomics Community (G3C) Role of Both the Genomics and other Factors in Human Disease Genome Analysis Technologies mhealth and Environmental Monitoring Technologies Eric D. Green, MD, PhD 15

16 Precision Medicine A broader context for individualizing medical care to advance human health Today: most medical care based on expected response of the average patient Tomorrow: medical care based on individual genomic, environmental, and lifestyle differences that enable more precise ways to prevent and treat disease Precision Medicine Concept is not entirely new: Prescription eyeglasses Blood transfusions What is needed now: Rigorous research program Multidisciplinary approach Audacious scale and scope President Barack Obama Jan 30, 2015 the budget I send this Congress on Monday will include a new Precision Medicine Initiative that brings America closer to curing diseases like cancer and diabetes, and gives all of us access, potentially, to the personalized information that we need to keep ourselves and our families healthier. Eric D. Green, MD, PhD 16

17 Precision Medicine Initiative: The Vision NEAR TERM: Cancer as a Model of Precision Medicine Cancer as leading edge of precision medicine, yet more to learn. Ramp up current efforts to include more cancer types LONGER TERM: Expanding the Model to Other Diseases Create national research cohort of >1 million volunteers. Generate knowledge base for precision medicine. POLICY CHANGES: Remove Barriers to Clinical Implementation Update federal rules protecting research participants. Advance FDA oversight of precision medicine products. Precision Medicine Initiative: Proposed Fiscal Year 2016 Funding National$200 Million FDA $10 Million Office of the National Coordinator for Health Information Technology $5 Million TOTAL $215 Million National Research Cohort >1 million U.S. volunteers Participants to share genomic data, lifestyle information, biological samples all linked to their EHRs Forge new model for doing science that emphasizes: Engaged participants Open, responsible data sharing Strong privacy protections Convert healthcare system into a learning system Eric D. Green, MD, PhD 17

18 Precision Medicine Initiative: Next Steps Working Group of Advisory Committee to the Director Additional meetings/workshops Implementation Trans NIH implementation model Fall 2015: Initial funding opportunities announced Fiscal Year 2016: Funding begins Emphasis on Transparency Planning a National Research Cohort Eric D. Green, MD, PhD 18

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association

Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Testimony of Christopher Newton-Cheh, MD, MPH Volunteer for the American Heart Association Before the House Energy and Commerce Subcommittee on Health 21st Century Cures: Examining the Regulation of Laboratory

More information

THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION

THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION William S. Dalton, PhD, MD AACR April 17, 2016 Designing a Federated Model To Support Research & Healthcare Offices

More information

Integrating Genomics in Family Medicine

Integrating Genomics in Family Medicine Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Integrating Genomics in Family Medicine Brian Stello MD Lehigh Valley Health Network, Brian.Stello@lvhn.org Follow this and

More information

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December

More information

AGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1

AGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1 AGRO/ANSC/BIO/GENE/HORT 305 Fall, 2016 Overview of Genetics Lecture outline (Chpt 1, Genetics by Brooker) #1 - Genetics: Progress from Mendel to DNA: Gregor Mendel, in the mid 19 th century provided the

More information

Personalized. Health in Canada

Personalized. Health in Canada Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute

More information

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 Submitted resources from physician organization representatives were mapped

More information

This Webcast Will Begin Shortly

This Webcast Will Begin Shortly This Webcast Will Begin Shortly If you have any technical problems with the Webcast or the streaming audio, please contact us via email at: webcast@acc.com Thank You! Personalized Medicine Promise and

More information

UNDERSTANDING GENETIC RESEARCH AND ALTERNATING HEMIPLEGIA OF CHILDHOOD. IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process

UNDERSTANDING GENETIC RESEARCH AND ALTERNATING HEMIPLEGIA OF CHILDHOOD. IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process IT ALL BEGINS WITH THE AHC PATIENT And The Scientific Process Genetic discovery AHC Patients Need Help! Researchers collect data on AHC patients (observation) Researchers interpret and evaluate data AHC

More information

The Future of HealthCare Information Technology

The Future of HealthCare Information Technology HST.921 / HST.922 Information Technology in the Health Care System of the Future, Spring 2009 Harvard-MIT Division of Health Sciences and Technology Course Directors: Dr. Steven Locke, Dr. Bryan Bergeron,

More information

Bridging the Genomics-Health IT Gap for Precision Medicine

Bridging the Genomics-Health IT Gap for Precision Medicine Domain Monitor: Analytics Bridging the Genomics-Health IT Gap for Precision Medicine By Jody Ranck The Reality of Precision Medicine Since the White House launched its Precision Medicine initiative in

More information

Learning Objectives. Introduction

Learning Objectives. Introduction Tools for Teaching Genetics in Primary Care Charles J. Macri, MD Leon Moore, Ph.D. NEGEA Baltimore, Maryland 3 March 2001 Learning Objectives Why is genetics an important topic for discussion now? Identify

More information

The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Catalog Addendum

The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Catalog Addendum The University of Texas MD Anderson Cancer Center UTHealth 2016-2018 Catalog Addendum GSBS 2016-18 Catalog Addendum Table of Contents School Name Change... 1 Areas of Research Concentration Changes...

More information

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER

More information

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results

More information

Genetics and Gene Therapy

Genetics and Gene Therapy Genetics and Gene Therapy Optional Homework Instructions: Print and read this article. Answer the questions at the end to the best of your ability. Extra credit will be given based on quality of responses.

More information

Genomic Medicine in France

Genomic Medicine in France Genomic Medicine in France Catherine Nguyen, PhD Director ITMO GGB Genetic, Genomic & Bioinformatic Advancing Disease Modeling in Animal-Based research in Support of Precision Medecine: a Workshop ILAR

More information

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution

More information

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome

More information

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego

Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Presented by: Tess L. Crisostomo Laboratory Quality Assurance/Compliance Officer Naval Medical Center San Diego Discuss the difference between DNA Genotyping and Genome Sequencing What makes you who you

More information

COPE. FAQs CORPORATE ONCOLOGY PROGRAM FOR EMPLOYEES

COPE. FAQs CORPORATE ONCOLOGY PROGRAM FOR EMPLOYEES COPE CORPORATE ONCOLOGY PROGRAM FOR EMPLOYEES FAQs This brochure addresses FAQ and is prepared solely for the German market. Local adjustments may be necessary. Please contact us if you require additional

More information

Controversy In Pharmacogenomics

Controversy In Pharmacogenomics Controversy In Pharmacogenomics Alejandra M. De Jesús-Soto, Mark R. Ruprecht, Patricia Vera-González Principal Investigator: Rafael Irizarry, PhD Graduate Assistant: William Townes, MS Harvard T.H. Chan

More information

NHS ENGLAND BOARD PAPER

NHS ENGLAND BOARD PAPER NHS ENGLAND BOARD PAPER Paper: PB.30.03.2017/06 Title: Creating a genomic medicine service to lay the foundations to deliver personalised interventions and treatments Lead Director: Professor Sir Bruce

More information

2017 Precision Medicine Study

2017 Precision Medicine Study 2017 Precision Medicine Study www.himssanalytics.com Enabling better health through information technology. Precision Medicine Study Introduction DNA genetic testing companies such as Ancestry.com and

More information

Big Data Era in Medicine

Big Data Era in Medicine Big Data Era in Medicine brought by Genome Omics Information Hiroshi Tanaka Tohoku Medical Megabank Organization Tohoku University and Dept. Biomedical Informatics Tokyo Medical and Dental University the

More information

CHARTING THE COURSE FOR PRECISION MEDICINE

CHARTING THE COURSE FOR PRECISION MEDICINE A Friends of Cancer Research White Paper CHARTING THE COURSE FOR PRECISION MEDICINE ADOPTING CONSENSUS ANALYTICAL STANDARDS AND STREAMLINING APPROVAL PATHWAYS FOR POST-MARKET MODIFICATIONS FOR NGS TESTS

More information

Regulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC

Regulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC Regulatory Overview of Proposed LDT Framework By Ben Berg, Meaghan Bailey, RAC On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) notified both the Senate Committee on Health,

More information

Personal Genomic Information Management and Personalized Medicine: Challenges, Current Solutions, and Roles of HIM Professionals

Personal Genomic Information Management and Personalized Medicine: Challenges, Current Solutions, and Roles of HIM Professionals Personal Genomic Information Management and Personalized Medicine: Challenges, Current Solutions, and Roles of HIM Professionals Personal Genomic Information Management and Personalized Medicine: Challenges,

More information

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview

SSPPS STRATEGIC PLAN. Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice. April 30, Overview SSPPS STRATEGIC PLAN Pharmacy Education, Pharmaceutical Sciences Research, Clinical Pharmacy Practice April 30, 2012 Overview Here we present the 2012-2017 strategic plan for the Skaggs School of Pharmacy

More information

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development

Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development Presentation to the Committee on Accelerating Rare Disease Research and Orphan Product Development 23 November 2009 Sharon F. Terry, MA President & CEO, Genetic Alliance Executive Director, PXE International

More information

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) TriMark Publications April 2007 Volume: TMRGER07-0401 GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS

More information

Translational Medicine From Discovery to Health

Translational Medicine From Discovery to Health Translational Medicine From Discovery to Health Jamal A. Ibdah, MD, PhD Sr. Associate Dean & Director, MU Institute for Clinical and Translational Science Translational Medicine Translational Medicine

More information

Targeted Sequencing in the NBS Laboratory

Targeted Sequencing in the NBS Laboratory Targeted Sequencing in the NBS Laboratory Christopher Greene, PhD Newborn Screening and Molecular Biology Branch Division of Laboratory Sciences Gene Sequencing in Public Health Newborn Screening February

More information

THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org

THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA themmrf.org ABOUT THE MULTIPLE MYELOMA RESEARCH FOUNDATION The Multiple Myeloma Research Foundation (MMRF) was established in 1998 by identical twin sisters

More information

Rare diseases in the 7th EU Framework Programme for Research and Technological Development

Rare diseases in the 7th EU Framework Programme for Research and Technological Development Rare diseases in the 7th EU Framework Programme for Research and Technological Development Manuel Hallen, MD Head of Unit Medical & Public Health Research DG Research European Commission 1 The role of

More information

Greenwood Genetic Center

Greenwood Genetic Center Greenwood Genetic Center: The Center for Human Genetics and The Partnership Campus A Growing Collaborative South Carolina Community Development Association Steve Skinner, M.D. Greenwood Genetic Center

More information

Reimbursement Strategy for Companion Diagnostics:

Reimbursement Strategy for Companion Diagnostics: Reimbursement Strategy for Companion Diagnostics: Emerging Models and Requirements Edward E. Berger, Ph.D. Larchmont Strategic Advisors Definition Companion diagnostic A diagnostic test used to predict

More information

Corporate Overview. March 2017

Corporate Overview. March 2017 Corporate Overview March 2017 Bionano Genomics Overview Commercial-stage company developing and selling instruments & consumables for whole genome analysis Addressing the needs for: A better understanding

More information

First Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing

First Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing First Do No Harm: Regulation and Clinical Integration of DTC Genetic Testing Amy L. McGuire, JD, PhD Center for Medical Ethics and Health Policy Baylor College of Medicine DTC Advertising Personal Genome

More information

TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS

TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS THE DOORS ARE OPEN: FEEL FREE TO COME IN CENTOGENE UNLOCKS THE POWER OF GENETIC INSIGHTS TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH GENETIC

More information

Types of Databases - By Scope

Types of Databases - By Scope Biological Databases Bioinformatics Workshop 2009 Chi-Cheng Lin, Ph.D. Department of Computer Science Winona State University clin@winona.edu Biological Databases Data Domains - By Scope - By Level of

More information

We've all heard the dismal statistics: 10,000 known diseases with only 500 treatments. Not great odds if you're a patient.

We've all heard the dismal statistics: 10,000 known diseases with only 500 treatments. Not great odds if you're a patient. No longer just passengers, patients are now co-pilots helping to navigate the future of medical progress. But until recently, the pace of progress has been slow. In some diseases, we still utter the words

More information

+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA

+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA At the Center for Infectious Disease Research, we use systems biology approaches and cutting-edge technologies to accelerate the development of life-saving drugs, diagnostics and treatments for the world

More information

Genomic Data Is Going Google. Ask Bigger Biological Questions

Genomic Data Is Going Google. Ask Bigger Biological Questions Genomic Data Is Going Google Ask Bigger Biological Questions You know your research could have a significant scientific impact and answer questions that may redefine how a disease is diagnosed or treated.

More information

Roundtable on Genomics and Precision Health Annual Report

Roundtable on Genomics and Precision Health Annual Report Roundtable on Genomics and Precision Health 2016 Annual Report Message from the Co-Chairs Geoffrey S. Ginsburg and Sharon F. Terry This past year we intentionally reflected on our efforts to date and brought

More information

Personal Genomics Platform White Paper Last Updated November 15, Executive Summary

Personal Genomics Platform White Paper Last Updated November 15, Executive Summary Executive Summary Helix is a personal genomics platform company with a simple but powerful mission: to empower every person to improve their life through DNA. Our platform includes saliva sample collection,

More information

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS 1. Introduction 1.1 This document provides guidance notes for the assessment of academic qualifications that have not been formally accredited

More information

ISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1

ISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1 Epidemiologic Research 1 December 12, 2006 Comments on 2006 CIOMS draft Special Ethical Considerations for Epidemiologic Research as proposed supplement to the updated 2002 CIOMS International Ethical

More information

Age-Adjusted Death Rates for Coronary Heart Disease, U.S.,

Age-Adjusted Death Rates for Coronary Heart Disease, U.S., Age-Adjusted Death Rates for Coronary Heart Disease, U.S., 1950-2004 Deaths/100,000 Population 600 500 400 300 200 100 Risk Factors U.S. Actual U.S. "Could Be" (Based on Japan Actual) 0 1950 1960 1970

More information

Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare

Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare The world of healthcare is changing - with two revolutionary technologies, genomics and blockchain poised to significantly

More information

Overview of Health Informatics. ITI BMI-Dept

Overview of Health Informatics. ITI BMI-Dept Overview of Health Informatics ITI BMI-Dept Fellowship Week 5 Overview of Health Informatics ITI, BMI-Dept Day 10 7/5/2010 2 Agenda 1-Bioinformatics Definitions 2-System Biology 3-Bioinformatics vs Computational

More information

Target Enrichment Strategies for Next Generation Sequencing

Target Enrichment Strategies for Next Generation Sequencing Target Enrichment Strategies for Next Generation Sequencing Anuj Gupta, PhD Agilent Technologies, New Delhi Genotypic Conference, Sept 2014 NGS Timeline Information burst Nearly 30,000 human genomes sequenced

More information

Nordic Register and Biobank Data

Nordic Register and Biobank Data Nordic Register and Biobank Data A basis for innovative research on health and welfare Juni Palmgren Karolinska Institutet, Stockholm Nordic conference on Real World Data Helsinki November 2016 Nordic

More information

Biomedical Big Data and Precision Medicine

Biomedical Big Data and Precision Medicine Biomedical Big Data and Precision Medicine Jie Yang Department of Mathematics, Statistics, and Computer Science University of Illinois at Chicago October 8, 2015 1 Explosion of Biomedical Data 2 Types

More information

Rare Diseases: Challenges and Opportunities NIH Perspective

Rare Diseases: Challenges and Opportunities NIH Perspective Rare Diseases: Challenges and Opportunities NIH Perspective Stephen C. Groft, Pharm.D. Office of Rare Diseases Research (ORDR) National Center for Advancing Translational Science (NCATS) National Institutes

More information

PLTW Biomedical Science Medical Interventions Course Outline

PLTW Biomedical Science Medical Interventions Course Outline Follow the fictitious Smith family as you learn about the prevention, diagnosis, and treatment of disease. Play the role of biomedical professionals to analyze case information and diagnose and treat your

More information

MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE

MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE MAYO CLINIC CENTER FOR BIOMEDICAL DISCOVERY EXCEPTIONAL RESEARCH LEADS TO EXCEPTIONAL PATIENT CARE THE RESEARCH WE DO TODAY WILL DETERMINE THE TYPE OF MEDICAL AND SURGICAL PRACTICE WE CARRY ON AT THE CLINIC

More information

article May 2008 Vol. 10 No. 5 BACKGROUND AND HISTORY DEFINITION OF LABORATORIES

article May 2008 Vol. 10 No. 5 BACKGROUND AND HISTORY DEFINITION OF LABORATORIES article May 2008 Vol. 10 No. 5 Molecular genetic testing for ultra rare diseases: models for translation from the research laboratory to the CLIA-certified diagnostic laboratory S. Das, PhD 1, Sherri J.

More information

Introduction to Pharmacogenetics Competency

Introduction to Pharmacogenetics Competency Introduction to Pharmacogenetics Competency Updated on 6/2015 Pre-test Question # 1 Pharmacogenetics is the study of how genetic variations affect drug response a) True b) False Pre-test Question # 2 Pharmacogenetic

More information

Human Genome. The Saudi. Program. An oasis in the desert of Arab medicine is providing clues to genetic disease. By the Saudi Genome Project Team

Human Genome. The Saudi. Program. An oasis in the desert of Arab medicine is providing clues to genetic disease. By the Saudi Genome Project Team By the Saudi Genome Project Team The Saudi image licensed by ingram publishing Human Genome Program An oasis in the desert of Arab medicine is providing clues to genetic disease. Digital Object Identifier

More information

PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS

PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS CLEAR DIAGNOSIS TARGETED TREATMENT STRENGTHENED RESEARCH SUMMARY NATIONAL STRATEGY FOR PERSONALISED MEDICINE 2017-2020 FOREWORD Personalised Medicine

More information

The Intersection of Genomics Research and the IDE Regulation

The Intersection of Genomics Research and the IDE Regulation The Intersection of Genomics Research and the IDE Regulation Katherine Donigan, Ph.D. Personalized Medicine Staff FDA/CDRH/OIR October 19, 2017 1 In Vitro Diagnostic (IVD) Regulation Through the 1976 medical

More information

Using Genome Sequencing in the Clinic will Change How You Practice Medicine, Educate and Conduct Research

Using Genome Sequencing in the Clinic will Change How You Practice Medicine, Educate and Conduct Research Using Genome Sequencing in the Clinic will Change How You Practice Medicine, Educate and Conduct Research Howard J. Jacob, Ph.D. Executive Vice President Genomic Medicine Chief Genomic Medicine Officer

More information

Genetic Variation and Genome- Wide Association Studies. Keyan Salari, MD/PhD Candidate Department of Genetics

Genetic Variation and Genome- Wide Association Studies. Keyan Salari, MD/PhD Candidate Department of Genetics Genetic Variation and Genome- Wide Association Studies Keyan Salari, MD/PhD Candidate Department of Genetics How many of you did the readings before class? A. Yes, of course! B. Started, but didn t get

More information

LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES

LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES LA RICERCA TELETHON PER LE MALATTIE RARE TELETHON RESEARCH ON RARE DISEASES Francesca Pasinelli Direttore Generale 3 Congresso Nazionale SIFaCT Roma, 9 ottobre 2015 About Telethon Fondazione Telethon is

More information

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Pediatric-Specific Provisions Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015 Requires the NIH to complete a strategic plan, and in the

More information

The Future of Clinical and Pharmaceutical Research

The Future of Clinical and Pharmaceutical Research The Future of Clinical and Pharmaceutical Research Petra Streng, Industry Business Unit Life Sciences, SAP AG Dr. René Fitterer, Public Services & Healthcare, SAP (Switzerland) Inc. SAP Forum Basel, 20

More information

Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013

Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013 Christopher P. Austin, M.D. Director, NCATS IOM CTSA Review Committee January 24, 2013 Basic Laboratory Research Clinical Research Improved Public Health Translational Research Population Research Basic

More information

Introduction to Next Generation Sequencing (NGS) Andrew Parrish Exeter, 2 nd November 2017

Introduction to Next Generation Sequencing (NGS) Andrew Parrish Exeter, 2 nd November 2017 Introduction to Next Generation Sequencing (NGS) Andrew Parrish Exeter, 2 nd November 2017 Topics to cover today What is Next Generation Sequencing (NGS)? Why do we need NGS? Common approaches to NGS NGS

More information

GENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE)

GENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE) TriMark Publications May 2008 Volume: TMRGEN08-0515 GENOMICS WORLD MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS 1. Introduction

More information

Second Quarter 2016 Financial Results. August 4, 2016

Second Quarter 2016 Financial Results. August 4, 2016 Second Quarter 2016 Financial Results August 4, 2016 Cautionary Note Regarding Forward-Looking Statements This presentation and various remarks we make during this presentation contain forward-looking

More information

Update on Current FDA Policies and Priorities

Update on Current FDA Policies and Priorities Update on Current FDA Policies and Priorities Vernessa Pollard MassMEDIC FDA Update December 12, 2017 Boston Brussels Chicago Dallas Düsseldorf Frankfurt Houston London Los Angeles Miami Milan Munich New

More information

Pharmacogenomics in Pain Management

Pharmacogenomics in Pain Management WHITE PAPER Pharmacogenomics in Pain Management Personalized Pain Therapy Authors: ANDREW PURCHASE, BSc Associate Director, Safety & Risk Management PRA Health Sciences LYNN WEBSTER, MD Vice President,

More information

Post-doctoral PharmD Fellowship Programs

Post-doctoral PharmD Fellowship Programs Post-doctoral PharmD Fellowship Programs Table of Contents About Bioverativ Messages from Medical & Regulatory Our Pipeline Partnership with Northeastern University Global Medical Fellowship Global Regulatory

More information

Lessons from the Human Genome Project that may be applicable to the Exposome Endeavor

Lessons from the Human Genome Project that may be applicable to the Exposome Endeavor Lessons from the Human Genome Project that may be applicable to the Exposome Endeavor Christopher P. Austin. M.D. Director, NIH Chemical Genomics Center Senior Advisor to the NHGRI Director for Translational

More information

Department of Pathology fonds

Department of Pathology fonds Department of Pathology fonds Compiled by Hemalatha Ramasamy (2005) Revised by Erwin Wodarczak (2008, 2009) Last revised November 2010 *** Institutional records -- researcher access subject to review ***

More information

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence

The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence The 100,000 Genomes Project Genomics Collaboration Event Finnish Residence Prof Mark Caulfield FMedSci Chief Scientist for Genomics England Barts Heart Centre William Harvey Research Institute Queen Mary

More information

CS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016

CS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016 CS273B: Deep Learning in Genomics and Biomedicine. Recitation 1 30/9/2016 Topics Genetic variation Population structure Linkage disequilibrium Natural disease variants Genome Wide Association Studies Gene

More information

Molecular Pathology: The Molecular Basis of Human Disease William B. Coleman, Gregory J. Tsongalis

Molecular Pathology: The Molecular Basis of Human Disease William B. Coleman, Gregory J. Tsongalis Molecular Pathology: The Molecular Basis of Human Disease William B. Coleman, Gregory J. Tsongalis 0080922198, 9780080922195 2009 Molecular Pathology: The Molecular Basis of Human Disease 664 pages Academic

More information

A pathogenic mutation was identified in the LDLR gene.

A pathogenic mutation was identified in the LDLR gene. Hereditary High Cholesterol Test ORDERING PHYSICIAN Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA SPECIMEN Type: Saliva Barcode: 333 234234 2343 Collected: Jul 15, 2017 Received: Jul 17,

More information

Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development A Workshop

Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development A Workshop A Collaboration between the Forum on Drug Discovery, Development, and Translation and the Roundtable on Genomics and Precision Health Enabling Precision Medicine: The Role of Genetics in Clinical Drug

More information

The IBM Reference Architecture for Healthcare and Life Sciences

The IBM Reference Architecture for Healthcare and Life Sciences The IBM Reference Architecture for Healthcare and Life Sciences Janis Landry-Lane IBM Systems Group World Wide Program Director janisll@us.ibm.com Doing It Right SYMPOSIUM March 23-24, 2017 Big Data Symposium

More information

MEANINGFUL USE CRITERIA PHYSICIANS

MEANINGFUL USE CRITERIA PHYSICIANS MEANINGFUL USE CRITERIA PHYSICIANS The first list is of the 25 Stage 1 Meaningful Use criteria for eligible providers (EP) and comes from the proposed rule: "Medicare and Medicaid Programs; Electronic

More information

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies Genome Wide Association Studies HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date 1.0 Purpose This policy describes how investigators at the University of South Florida (USF) and USF Affiliates

More information

The Integrated Biomedical Sciences Graduate Program

The Integrated Biomedical Sciences Graduate Program The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to

More information

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not

More information

BIOCRATES Life Sciences AG Short Company Presentation

BIOCRATES Life Sciences AG Short Company Presentation BIOCRATES Life Sciences AG Short Company Presentation Dr. Alexandra C. Gruber MBA MMFin Director Business Development / Marketing Austria Showcase Life Science Japan, Tokyo, December 2010 BIOCRATES Life

More information

Building on the NHLBI Legacy of Hypertension Research:

Building on the NHLBI Legacy of Hypertension Research: Building on the NHLBI Legacy of Hypertension Research: Charting Our Future Together Gary H. Gibbons, M.D. Director National Heart, Lung, and Blood Institute AHA Council on Hypertension September 16, 2015

More information

Visions on the role of Statisticians in the Pharmaceutical Industry. Merete Jørgensen President EFSPI VP Biostatistics, Novo Nordisk A/S

Visions on the role of Statisticians in the Pharmaceutical Industry. Merete Jørgensen President EFSPI VP Biostatistics, Novo Nordisk A/S Visions on the role of Statisticians in the Pharmaceutical Industry Merete Jørgensen President EFSPI VP Biostatistics, Novo Nordisk A/S Overview of presentation Vision & Mission A Historical view New Statistical

More information

Insights into the Rare Disease Drug Approval Landscape: Trends and Current Development

Insights into the Rare Disease Drug Approval Landscape: Trends and Current Development Insights into the Rare Disease Drug Approval Landscape: Trends and Current Development Mike Lanthier Operations Research Analyst FDA Office of the Commissioner NORD Rare Diseases & Orphan Products Breakthrough

More information

Lecture #1. Introduction to microarray technology

Lecture #1. Introduction to microarray technology Lecture #1 Introduction to microarray technology Outline General purpose Microarray assay concept Basic microarray experimental process cdna/two channel arrays Oligonucleotide arrays Exon arrays Comparing

More information

Using local RWD to drive global therapeutic advancements.

Using local RWD to drive global therapeutic advancements. Using local RWD to drive global therapeutic advancements. Helsinki, 30 th Nov 2016 Mike Spencer, Head of Real World Evidence, EMEA, Janssen The following represent my own views and not necessarily those

More information

Bachelor of Science (Hons) / Bachelor of Science Biomedical Science

Bachelor of Science (Hons) / Bachelor of Science Biomedical Science Bachelor of Science (Hons) / Bachelor of Science Biomedical Science Awarded by In collaboration with This degree course is designed to give you a broad understanding of the scientific investigation of

More information

Nanotechnology and Advanced Materials for more effective Healthcare

Nanotechnology and Advanced Materials for more effective Healthcare Nanotechnology and Advanced Materials for more effective Healthcare This challenge taps into the potential of nanotechnologies and advanced materials to enable more effective therapies and diagnostics

More information